Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors
Top Cited Papers
Open Access
- 23 May 2005
- journal article
- Published by Rockefeller University Press in The Journal of cell biology
- Vol. 169 (4) , 681-691
- https://doi.org/10.1083/jcb.200409115
Abstract
Vascular endothelial growth factor (VEGF) is a critical mediator of blood vessel formation during development and in pathological conditions. In this study, weKeywords
This publication has 52 references indexed in Scilit:
- Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNature Reviews Drug Discovery, 2004
- Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZFThe Journal of cell biology, 2003
- The biology of VEGF and its receptorsNature Medicine, 2003
- Extracellular matrix‐bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligationThe FASEB Journal, 2003
- Inflammation and cancerNature, 2002
- ErbB4 and Its Isoforms Selective Regulation of Growth Factor Responses by Naturally Occurring Receptor VariantsTrends in Cardiovascular Medicine, 2000
- Regulation of Angiostatin Production by Matrix Metalloproteinase-2 in a Model of Concomitant ResistancePublished by Elsevier ,1999
- VEGF145, a Secreted Vascular Endothelial Growth Factor Isoform That Binds to Extracellular MatrixJournal of Biological Chemistry, 1997
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993